|
GCFC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.740000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.083800E-02 |
| Normal-vs-Stage2 |
3.078100E-03 |
| Normal-vs-Stage3 |
1.944370E-03 |
| Normal-vs-Stage4 |
2.390200E-01 |
| Stage1-vs-Stage2 |
7.746000E-02 |
| Stage1-vs-Stage3 |
5.787800E-02 |
| Stage1-vs-Stage4 |
7.767800E-01 |
| Stage2-vs-Stage3 |
7.298800E-01 |
| Stage2-vs-Stage4 |
3.534200E-01 |
| Stage3-vs-Stage4 |
4.580600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.272480E-02 |
| Normal-vs-AfricanAmerican |
3.584800E-01 |
| Normal-vs-Asian |
5.397600E-01 |
| Caucasian-vs-AfricanAmerican |
7.568200E-01 |
| Caucasian-vs-Asian |
2.447200E-01 |
| AfricanAmerican-vs-Asian |
6.052600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.130400E-01 |
| Normal-vs-Female |
4.197100E-03 |
| Male-vs-Female |
2.332800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.714000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.038190E-02 |
| Normal-vs-Age(61-80Yrs) |
3.661700E-02 |
| Normal-vs-Age(81-100Yrs) |
3.68480000001448E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.783040E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.541600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.025060E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.369000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.481730E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.137760E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.020800E-04 |
| Classical-VS-Follicular |
2.032600E-01 |
| Classical-VS-Other |
4.982200E-01 |
| Classical-VS-Normal |
1.230760E-01 |
| Tall-VS-Follicular |
4.654200E-02 |
| Tall-VS-Other |
1.380820E-01 |
| Tall-VS-Normal |
3.85969999999736E-05 |
| Follicular-VS-Other |
2.097000E-01 |
| Follicular-VS-Normal |
2.815700E-02 |
| Other-VS-Normal |
7.190000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.521400E-03 |
| Normal-vs-N1 |
9.928400E-01 |
| N0-vs-N1 |
1.234950E-01 |
|
|
